Product Information
BOVISEAL
Bismuth Subnitrate 2.6g INDICATIONS •B oviseal is suitable to use with any antibiotic dry cow treatment • Reduces new intramammary infections in the dry period • Reduces clinical mastitis in subsequent lactation
BENEFITS • Seals the teat from drying off until calving • Protection for the entire dry cow period thus reducing cases of dry cow mastitis • Fewer cases of mastitis in the next lactation • Proven efficacy in mastitis prevention through trial work and customer satisfaction • Nil milk withdrawal • Can be combined with dry cow therapy for a cost effective approach to mastitis prevention and control LIST NO.
UNIT
Case
1BOV026
120 syringes
1
Correct Infusion is Vital For Teat Sealing Success Get your farm customers to follow these steps for perfect application; 1. Teats should be clean and dry. If teats are not clean, CAREFULLY wash and dry them prior to disinfection 2. Always use a new pair of gloves. Disinfect the teat. Repeat until the teat wipe comes away clean 3. If using Antibiotic Dry Cow Therapy in combination with Boviseal, apply one ADCT tube per quarter and then repeat the disinfection procedure 4. Pinch the base of teat at the udder attachment. Infuse Boviseal use one complete syringe per quarter. Do not massage. Boviseal must remain in the teat canal 5. Apply a post-milking disinfectant to cover each teat. Mark each treated cow and keep her away from the milk supply. Treated animals should be allowed to stand for 30 minutes to allow the teat to close Bimeda Inc.® Unit 2, Bryn Cefni Industrial Park Llangefni, Anglesey, Wales, LL777XA
Global Excellence In Animal Health
www.bimeda.co.uk
Technical Information
BOVISEAL
Bismuth Subnitrate 2.6g PRESENTATION Boviseal is an off-white smooth paste. It is presented in syringes each containing 4g intramammary infusion containing 65% Bismuth Subnitrate, in a mineral oil vehicle. TARGET SPECIES Dairy cows. USES Boviseal is indicated for the prevention of new intramammary infections throughout the dry period. This results in a reduction in the incidence of sub clinical mastitis in cows at calving, and of clinical mastitis in the dry period and the subsequent lactation. It is recommended that Boviseal be used as part of a herd approach to dry cow management and mastitis control. Cows free of sub clinical mastitis can be given Boviseal on its own at drying off according to the criteria below. Other animals should be managed in accordance with an approved mastitis control plan or specific veterinary advice and receive the appropriate antibiotic dry cow therapy before Boviseal infusion. For practical purposes, selection criteria may be based on the mastitis and cell count history of individual cows, or recognised tests for the detection of sub clinical mastitis or bacteriological sampling. CONTRA – INDICATIONS & WARNINGS Not intended for use in cows with a suspected or confirmed intramammary infection at drying off. Do not use in the lactating cow. If lactating cows are accidentally infused the seal can easily be stripped out manually and no additional precautions are needed. If a sealed quarter develops clinical mastitis the affected quarter should be stripped out manually before appropriate antibacterial therapy is instituted. For single use only.
AMOUNTS TO BE ADMINISTERED AND ADMINISTRATION ROUTE One syringe into each udder quarter immediately after the last milking of the lactation (at drying off ). At drying off the teat should be thoroughly cleaned and disinfected, and it should be allowed to dry before infusion; this is essential, as Boviseal possesses no antimicrobial activity. Care should also be taken to avoid contamination of the syringe nozzle. Squeeze base of teat with one hand and insert nozzle into the teat and apply gentle and continuous pressure until the paste is expressed. After infusion of the product stop squeezing base of teat only after removal of nozzle from teat. USEFUL INFORMATION Most of the seal comes out at the first stripping, suckling or milking after calving, but small amounts may occasionally be seen for a few days as flecks on the filter. Boviseal can be differentiated from mastitis by its texture. Under cold conditions the product may be warmed to room temperature in a warm environment, to aid syringeability. Individual tubes must not be placed in warm water. Any unused product or waste material should be disposed of in accordance with national requirements. WITHDRAWAL PERIOD(S) Meat and offal: zero days Milk: zero days LEGAL CATEGORY POM-V MARKETING AUTHORISATION HOLDER Bimeda Chemicals Ltd., Broomhill Road, Tallaght, Dublin 24. Ireland. MARKETING AUTHORISATION NUMBER VM 41966/4001
The Sense in Sealing A Reading University/DAISY survey1 claimed that clinical cases of mastitis are in the region 43 cases per 100 cows and it is estimated that a typical mastitis case costs somewhere between £150 - £200. For Irish farmer Patrick Kelly the value of a teat seal is well proven as part of his mastitis control strategy. With Bimeda support he undertook his own teat seal evaluation at Waterwheel Farm, Donegal, North-West Ireland. Conducted with 60 randomly selected cows it showed a significant reduction in mastitis cases and return on investment from using Boviseal. In two years a 50% reduction in clinical mastitis cases was recorded from the use of Boviseal with an antibiotic. In the year before Boviseal use, mastitis incidence was 26 cases/100 cows. In the first year this fell to 14/100 cows and after the entire herd was dried off with Boviseal and given an antibiotic treatment, incidence fell again to just 9 cases/100 cows. At the conclusion of the initiative, the farmer Mr Kelly calculated that treatment of the entire herd using Boviseal at drying off gave a return on investment of 300%. 1 Reading University/DAISY
Recent Irish Farm Case Study Data Mastitis cases per 100 cows 30 25 20 15 10
Antibiotic Dry Cow therapy only 60 cows treated with Boviseal + antibiotic
5
Global Excellence In Animal Health
www.bimeda.co.uk
0
2008
2009
100% of cows treated with Boviseal + antibiotic
2010